Verve Therapeutics, Inc. (NASDAQ:VERV – Get Free Report) has received a consensus rating of “Buy” from the six brokerages that are presently covering the stock, MarketBeat reports. Six investment ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

According to a new study inclisiran, given as a twice-yearly injection, significantly lowers LDL cholesterol in low-risk patients who are not on any lipid-lowering treatment at present. This ...

Lipid management for woman requires personalized care that considers sex-specific conditions across the reproductive lifespan ...